Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The bottom line is (Note in Bold)

"So then the pr will read...PTSC posts 85% gain in annual net revenue .06 per dilluted share."  Yea, that works.

Previous EPS was .03, with a 17.14 P/E multiple (per Yahoo quotes) putting us at a supposed ~52 cents PPS.  Now, with this new EPS (doubled) and that same (low - IMO) P/E multiple should put us at over a buck PPS tomorrow.  "Should".....  Of course, IMO, our P/E multiple should be more like 30.  Another "should".  More than likely our PPS will continue to hang around 50 cents till the next "event", making our P/E multiple under 10 again.  What BS, IMO.  Oh well.....

SGE

 

Share
New Message
Please login to post a reply